Researched against FDA labeling, published clinical-trial data (STEP-1 / SURMOUNT-1), and Hers's live pages, not a paid placement.
Hers GLP-1 Review
The women's health arm of Hims & Hers Health (NYSE: HIMS). In 2026 Hers signed a direct Novo Nordisk partnership adding FDA-approved Wegovy (pen and pill) at $149/mo and Zepbound via the Lilly partnership, alongside their existing compounded semaglutide and new compounded tirzepatide programs.
The 2026 Novo Nordisk partnership makes Hers materially different from where it was a year ago, FDA-approved Wegovy pen and pill from $149/mo is one of the cheapest brand-name GLP-1 routes available. Full verdict ↓
Clinical evidence: 20.9% average body-weight reduction at 72 weeks in SURMOUNT-1 (NEJM, 2022). Individual results vary; compounded GLP-1s are not FDA-approved.
Summarize this article with
Hers scores 7.3/10 in our independent review, starting at $199/mo for brand-name and compounded GLP-1 medications. The 2026 Novo Nordisk partnership changed Hers' product materially, FDA-approved Wegovy pen and Wegovy oral pill now start at $149/mo, making Hers one of the cheapest brand-name GLP-1 routes on the market. The platform also added compounded tirzepatide ($199–$299/mo) and Zepbound access via the Lilly partnership.
What makes it different: The only major women-focused telehealth platform with both a direct Novo Nordisk partnership (Wegovy pen + pill from $149/mo) and a Lilly partnership (Zepbound access) alongside compounded semaglutide and tirzepatide.
At a glance
- Women who want brand-name Wegovy at market-leading cash pricing ($149/mo), or a female-focused telehealth experience from a trusted NYSE-listed brand with integrated health services.
- Women who want personalized high-touch care or the absolute lowest compounded price. Men should see Hims instead.
Hers Pros and Cons
What We Like
- +2026 Novo Nordisk partnership, FDA-approved Wegovy pen and Wegovy oral pill from $149/mo, one of the lowest brand-name GLP-1 prices on the market
- +Zepbound access via the Lilly/Hims-Hers partnership announced 2026
- +Publicly traded company (NYSE: HIMS) with strong financial backing and regulatory compliance
- +Broader women's health platform, integrates weight loss with hormonal, skin, and wellness services
What Could Be Better
- −Membership + medication are billed separately ($39 first month / $149 ongoing membership), so total both line items before comparing prices
- −Support runs at big-platform scale, fine for routine refills, less personal if you want high-touch care
- −Compounded pricing starts at $199/mo with stepped pricing at higher doses, budget for the dose you'll end up on, not the entry dose
- −Zepbound access priced at ~$1,899/mo (brand cash) via the Lilly partnership, read as access, not value
What it costs
Headline pricing, full-year math, and how Hers compares to the closest alternatives.
Quick facts
All pricing tiers
Brand Wegovy Pen or Pill
$149/moFDA-approved Wegovy pen or oral pill via the 2026 Novo Nordisk partnership, one of the lowest brand-name cash prices available
Compounded Semaglutide Injection
$199/moAll-inclusive compounded semaglutide with consultations and free shipping
Compounded Tirzepatide
$199/moCompounded tirzepatide injectable (added 2026); higher doses reach $299/mo
Zepbound (Brand via Lilly partnership)
$1899/moFDA-approved Zepbound access via the Lilly/Hims-Hers partnership, brand cash price
Cancellation policy: Cancel anytime online or through the app
What third-party review aggregators say about Hers. Cards show the verified primary metric only, “Not found” means no public profile surfaced in our verification pass.
Hers (forhers.com) holds a middling Trustpilot TrustScore of 3.4 across several thousand reviews and parent company Hims & Hers is BBB-accredited, but third-party sentiment skews negative on operations: PissedConsumer rates it 1.8/5 with recurring complaints about unauthorized charges, hard-to-cancel subscriptions, refused refunds, and slow support. Separately, the FDA has criticized its compounded-semaglutide weight-loss marketing as 'false or misleading.'
Reddit: Discussion is dominated by regulatory news (FDA called Hers' compounded-semaglutide marketing 'false or misleading') and consumer billing complaints; positive efficacy stats circulating are company-published, not independent user reviews.
Trustpilot: Verified June 19, 2026, external-reviews verification pass.
Download the Hers App & Complete Intake
Download the Hers app, create an account, and complete a women-focused health questionnaire covering your medical history and weight loss goals.
Provider Review
A licensed provider reviews your health profile and, if approved, prescribes compounded semaglutide. Most reviews are completed within 24 hours.
Monthly Auto-Delivery
Compounded semaglutide ships free to your door monthly. Manage prescriptions, message providers, and access women's health resources through the Hers app.
Medications available
Ready to check Hers's pricing for yourself?
Visit HersSix trust signals, how we checked them, and what's been updated since the last review.
What the doctors say about GLP-1 medications
Independent, sourced clinical context on the medication class, not a comment on this provider.
“So-called 'weight loss drugs' like semaglutide have proven benefits beyond reducing the number on the scales – they are now considered important medicines for preventing deadly heart attacks and strokes. Today's guidance will no doubt help save lives as cardiovascular disease is still one of the country's biggest killers.”
“Anyone who has an active contraindication for the medication, where they have had an issue, for example, medullary thyroid cancer. If they are actively in a pancreatitis flare, obviously, you wouldn't apply this medication. It's, frankly, contraindicated in those situations.”
Quotes are general medical commentary about GLP-1 medications, independently sourced and not solicited by GLP-1 Picks. They are not an endorsement of any provider, our provider scores are set solely by our published methodology.
Common questions
Questions readers ask about Hers, similar providers to compare, and quick tools.
Frequently Asked Questions
How much is Wegovy through Hers?+
Does Hers offer tirzepatide or Zepbound?+
Is Hers the same as Hims for GLP-1?+
People also compare Hers
Alternatives to Hers
Similar providers by type, price, and features
Wegovy vs Zepbound (June 2026): SURMOUNT-5 Head-to-Head, Wegovy HD, & Cost Comparison
Cost & InsuranceGLP-1 Cost 2026: Wegovy, Zepbound & Ozempic Prices ($25–$1,350/mo)
Cost & InsuranceMedicare GLP-1 Coverage July 2026: $50/mo Wegovy + Zepbound Bridge Program Guide
Still comparing?
See how Hers compares to other GLP-1 programs.
Ready to get started with Hers?
Starting at $199/mo. See if you qualify today.
Visit HersOr jump to a specific program
FDA-approved Wegovy pen or oral pill via the 2026 Novo Nordisk partnership, one of the lowest brand-name GLP-1 cash prices on the market. Routes to the cobranded GLP-1 funnel.
Compounded semaglutide ($199/mo) or compounded tirzepatide ($199–$299/mo) through Hers's compounded GLP-1 program. Routes to the Hers-branded compounded funnel.